VERTEX PHARMACEUTICALS INC / MA

Pharmaceutical Preparations·BOSTON, MA·FY end 12/31·CIK 875320

Board of Directors

11 members · 9 independent · FY 2025

Director	Role	Tenure	Age	Committees	Indep.	Annual fees
Sangeeta Bhatia	Director	9y	57	TechNCG		—
Lloyd Carney	Director	5y	64	NCGAudit		—
Alan Garber	Director	7y	70	NCGTech		—
Reshma Kewalramani	Director · CEO	4y	53	—	—	—
Michel Lagarde	Director	1y	52	Audit		—
Jeffrey Leiden	Chair	15y	70	—	—	—
Diana McKenzie	Director	4y	61	AuditComp		—
Bruce Sachs	Lead Independent	26y	66	CompNCG		—
Jennifer Schneider	Director	0y	51	Comp		—
Nancy Thornberry	Director	1y	69	Tech		—
Suketu Upadhyay	Director	2y	57	AuditComp		—

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.